1571 Objectives FDG uptake in prostate cancers is commonly low for unclear reasons. We
examined RNA transcriptomes of prostate cancer vs. normal prostate using microarray …

1450 Objectives To explore underlying biological processes of low FDG uptake in prostate
cancer using gene expression, measured by array chips (over 20,000 transcripts and …

1608 Objectives The molecular basis of increased lung cancer glycolysis has not been
comprehensively assessed. We examined the RNA transcriptomes of lung cancer vs. normal …

The role of positron emission tomography (PET) with [F-18]-fluorodeoxyglucose (FDG) for
the imaging evaluation of patients who have cancer has expanded rapidly worldwide. The …

1343 Learning Objectives 1. FDG-PET can be used for staging of prostate cancers other
than conventional acinar adenocarcinoma. 2. Prostate cancers of unusual histology …

1144 Objectives FDG PET can be limited in the evaluation of prostate cancer. Several other
PET tracers show promise. Using whole genome microarray profile of cell lines, we …

18 Objectives FDG PET provides useful information for lung cancer management, although
FDG uptake can be present during infection and inflammation. FLT as a DNA synthesis …

518 Objectives: Prostate carcinoma is presently the most common neoplasm in men. It has
been clearly established that, due to the prostate9s low glycolytic activity, FDG-PET is …

413 Objectives: Prostate cancer is characterized by slow glycolysis and low FDG avidity on
PET imaging. We hypothesize that fatty acid rather than glucose metabolism is the dominant …

396 Objectives: Transport and phosphorylation of F-18-Deoxyglucose (FDG) in tumor cells
determine primarily the FDG kinetics. Other biological processes like proliferation may have …